- Role of renal function and cardiac biomarkers (NT-proBNP and Troponin) in determining mortality and cardiac outcome in atheromatous renovascular diseaseConstantina Chrysochou
Department of Renal Medicine, Salford Royal Hospitals NHS Foundation Trust, Manchester, UK
Kidney Blood Press Res 32:373-9. 2009..We aimed to see if these markers could be used as prognostic indicators of cardiovascular events (CVEs) and death in ARVD...
- Reverse cardiac remodelling and renal functional improvement following bilateral renal artery stenting for flash pulmonary oedemaConstantina Chrysochou
Manchester Academic Health Science Centre, Renal Department, Salford Royal Hospital, The University of Manchester, Salford, UK
Nephrol Dial Transplant 28:479-83. 2013..4 to 34.2 mL/min). This report provides new insights into the pathophysiological relationships between renal and cardiac changes in AFPO; the extent of the cardiac morphological changes was striking and unexpected...
- Dispelling the myth: the use of renin-angiotensin blockade in atheromatous renovascular diseaseConstantina Chrysochou
Renal Department, Salford Royal Hospital, Manchester Academic Health Science Centre, The University of Manchester, Salford, UK
Nephrol Dial Transplant 27:1403-9. 2012..This reservation is mostly because of fear of precipitating acute renal deterioration. We aimed to study whether RAB can be used safely in ARVD patients and whether it altered their outcome...
- BOLD imaging: a potential predictive biomarker of renal functional outcome following revascularization in atheromatous renovascular diseaseConstantina Chrysochou
The University of Manchester, Manchester Academic Health Science Centre, Salford Royal Hospital, Salford, UK
Nephrol Dial Transplant 27:1013-9. 2012..Blood oxygen level-dependent (BOLD) magnetic resonance imaging (MRI) does not require contrast administration and is sensitive to changes in tissue concentration of deoxyhaemoglobin...
- Magnetic resonance imaging: advances in the investigation of atheromatous renovascular diseaseC Chrysochou
Renal Department, Salford Royal Hospital NHS Foundation Trust, Salford, Manchester UK
J Nephrol 21:468-77. 2008..This review summarizes the multipurpose benefits of MR in the assessment of ARVD...
- Proteinuria as a predictor of renal functional outcome after revascularization in atherosclerotic renovascular disease (ARVD)C Chrysochou
Department of Renal Medicine, Salford Royal Hospital, Salford, UK
QJM 102:283-8. 2009....
- Gadolinium-enhanced magnetic resonance imaging for renovascular disease and nephrogenic systemic fibrosis: critical review of the literature and UK experienceConstantina Chrysochou
Renal Department, Salford Royal Hospital, Manchester, UK
J Magn Reson Imaging 29:887-94. 2009..We believe that positive reporting bias has prevailed in the literature and that very few patients with a glomerular filtration rate (GFR) 15-29 mL/min (stage 4 chronic kidney disease [CKD]) should be regarded as high risk...
- Low risk for nephrogenic systemic fibrosis in nondialysis patients who have chronic kidney disease and are investigated with gadolinium-enhanced magnetic resonance imagingConstantina Chrysochou
Renal Department, Salford Royal Hospital, Stott Lane, Salford, Greater Manchester, M6 8HD, UK
Clin J Am Soc Nephrol 5:484-9. 2010..We analyzed the safety of Gd-MRI in patients with CKD and varying levels of estimated GFR (eGFR)...